Rizalyn Golnar

Rizalyn Golnar is the Sr. Vice President of Clinical Operations of Kriya Therapeutics. Ms. Golnar joined Kriya from Xenon Pharmaceuticals and has over 20 years of pharmaceutical and biotech experience. Ms. Golnar held various positions of increasing responsibility within Clinical Operations at large pharmaceutical and start-up/pre-commercial stage companies. For the past several years, Ms. Golnar has also been responsible for building and leading this functional area within these companies. During her career, Ms. Golnar has been responsible for the operational delivery of small molecule, stem cell, and gene therapy programs in the areas of infectious, musculoskeletal, inflammatory, and neurological diseases.

Ms. Golnar received her undergraduate degree in biological sciences from Rutgers University.